skip to content

Department of Chemical Engineering and Biotechnology

Innovation Centre in Digital Molecular Technologies

An incubator supporting UK SMEs in the transformation of chemistry into the digital domain

The Innovation Centre in Digital Molecular Technologies is an open innovation research centre, co-funded by the University of Cambridge, AstraZeneca, Shionogi and the European Regional Development Fund. 

It is housed in the Yusuf Hameid Department of Chemistry with facilities that will include two refurbished labs and offices to host collaborative projects. 

The iDMT's mission is to support UK SMEs in:

  • establishing new products and services to support the digital transformation of molecular industries, and
  • exploiting the power of artificial intellgence and machine learning in molecular sciences, technologies and products. 

It is directed by Alexei Lapkin, our Professor of Sustainable Reaction Engineering, and involves a number of our academics and researchers. 

Visit the iDMT website to find out more and contact the iDMT team to discuss collaborative projects with the centre.

The iDMT is supported by

Latest news

Cambridge and Berkeley unravel the complex reaction pathways in zero carbon fuel synthesis

11 January 2023

Their research provides insight into how the chemical industry, which is the third largest subsector in terms of direct CO2 emissions, can recycle its own waste within current manufacturing processes.

MAI-SIM: structured illumination microscopy for the masses

21 December 2022

Our Laser Analytics group hit the history books to develop a superresolution microscopy technique that will allow more research into the origin and treatment of diseases such as Alzheimer’s and cancer.

Professor Lisa Hall awarded MRC Millennium Medal for 'pioneering multidisciplinary work' in biosensors

8 December 2022

Professor Hall is recognised for her translational research, which has delivered more than 8 million devices to support diabetes care, and her development of environmentally sustainable local manufacturing techniques that will benefit both the NHS and low and middle-income countries globally.